MYBORTE 3.5 MG
bortézomib
Public price
4.774,00 MAD
Active substance
bortézomib
Laboratory
SOTHEMA
What is this medicine?
MYBORTE 3.5 MG contains bortézomib. Its clinical use depends on the approved indication for this substance and the pharmaceutical form available in Morocco.
Verified summary
bortézomib, Poudre pour solution injectable, 3.5 MG, Boite d'un flacon
Common uses
General use context: injectable or infusion form, usually used under healthcare-professional supervision.
Class
Générique
Laboratory
SOTHEMA
Hospital price
4.502,00 MAD
Strength
3.5 MG
Form
Poudre pour solution injectable
Presentation
Boite d'un flacon
ATC code
L01XX32
Type
Générique
This information is informational and must be confirmed by a pharmacist or doctor. Do not change medicine or dosage based only on this page.
Price history
Reference price recorded since 2026-06-02: 4.774,00 MAD
Available presentations and strengths
Medicines with the same active substance
VELCADE
1 MG · BOITE DE 1 FLACON DE 10 ML
1,37 MAD
CYTOMIB
3,5 MG · BOITE DE 1 FLACON DE 10 ML
3,31 MAD
BORT SPAL 2
2 MG · BOITE DE 1 FLACON
3,38 MAD
VEELBORE
3,5 MG · BOITE DE 1
3,65 MAD
BORT SPAL
3.5 MG · BOITE DE 1 FLACON
5,62 MAD
BORTEA
3.5 MG · BOITE D'UN FLACON
5,62 MAD
VELCADE
3,5 MG · BOITE DE 1 FLACON DE 10 ML
5,86 MAD
VELCADE 1 MG
1 MG · Flacon de 5 ml
1.367,00 MAD
CYTOMIB 3.5 MG
3.5 MG · Boite de 1 flacon de 10 ML
3.306,00 MAD
BORT SPAL 2 MG
2 MG · Boite de 1 flacon
3.381,00 MAD
BORT SPAL 2 MG
2 MG · Poudre pour solution injectable
3.381,00 MAD
VEELBORE 3.5 MG
3.5 MG · Boite de un flacon de 8 ML
3.650,00 MAD